Universal Health Realty Income Trust Reports 2025 Financial Results
- Net Income Decline: For Q4 2025, net income was $4.3 million, or $0.31 per diluted share, down from $4.7 million and $0.34 in Q4 2024, primarily due to income loss from a medical office building in Amarillo, Texas, indicating challenges in the leasing market.
- Funds from Operations: The FFO for Q4 2025 slightly decreased to $11.74 million, or $0.85 per diluted share, reflecting the company's ability to manage costs effectively despite revenue declines, showcasing financial resilience.
- Dividend Payment: A dividend of $0.745 per share, totaling $10.3 million, was declared for Q4 2025, demonstrating the company's commitment to shareholder returns despite income pressures, indicating strong cash flow management.
- New Project Development: In October 2025, the company entered a ground lease with UHS to develop the Palm Beach Gardens Medical Plaza I, an 80,000 square foot medical office building with an estimated cost of $34 million, expected to be completed in Q4 2026, reflecting confidence in future growth opportunities.
Trade with 70% Backtested Accuracy
Analyst Views on UHT
About UHT
About the author

- Earnings Per Share: Universal Health REIT reported a Q1 GAAP EPS of $0.36, indicating resilience in maintaining profitability despite economic fluctuations, which is crucial for investor confidence in uncertain markets.
- Slight Revenue Decline: The revenue for the first quarter was $24.53 million, reflecting a minor year-over-year decrease of 0.1%, suggesting that increased competition in the healthcare REIT sector may pressure future revenue growth, warranting close monitoring of market trends.
- Investor Appeal: Universal Health REIT is viewed as a solid income investment through economic cycles, highlighting its stable cash flow and dividend policy, which may attract income-seeking investors and enhance its market appeal.
- Financial Transparency: The company has provided comprehensive financial information and historical earnings data, which boosts investor confidence in its financial health and offers potential investors a solid basis for decision-making, thereby increasing market interest in its stock.
- Net Income Growth: In Q1 2026, Universal Health Services reported net income of $348.7 million, or $5.65 per diluted share, compared to $316.7 million and $4.80 per diluted share in Q1 2025, indicating a significant improvement in profitability and reflecting strong performance in the healthcare sector.
- Significant Revenue Increase: The net revenues for Q1 2026 reached $4.495 billion, a 9.6% increase year-over-year, demonstrating sustained demand in acute care and behavioral health services, which enhances the company's competitive position in the industry.
- Strong EBITDA Performance: The EBITDA for Q1 2026 was $651.7 million, up 9.5% from $603.9 million in Q1 2025, showcasing ongoing improvements in operational efficiency and cost control, further solidifying the company's financial health.
- Robust Cash Flow: The net cash provided by operating activities for Q1 2026 was $402 million, an increase of $42 million from $360 million in 2025, reflecting significant enhancements in cash management and operational efficiency, thereby strengthening the company's capacity for future investments and expansion.
- Net Income Growth: For Q1 2026, Universal Health Realty reported a net income of $5 million, or $0.36 per diluted share, reflecting an increase from $4.8 million and $0.34 per diluted share in Q1 2025, primarily driven by reduced interest expenses and increased property income, thereby enhancing the company's profitability.
- Funds from Operations Performance: The FFO for the first quarter was $12.3 million, or $0.88 per diluted share, up from $11.9 million and $0.86 per diluted share in Q1 2025, indicating significant operational efficiency improvements amid rising revenues and depreciation expenses.
- Dividend Payment Update: A dividend of $0.745 per share, totaling $10.3 million, was declared for Q1 2026 and paid on March 31, demonstrating the company's ongoing commitment to stable cash flow and shareholder returns.
- Credit Agreement Amendment: In April 2026, the company increased its borrowing capacity under its credit agreement from $425 million to $475 million, with the maturity date remaining unchanged at September 30, 2028, enhancing financial flexibility and supporting future investment strategies.
Universal Health Reality: The article discusses the financial performance of Universal Health Reality, highlighting its net income for the first quarter.
Net Income Report: Universal Health Reality reported a net income of USD 5.019 million for Q1, indicating its financial health and operational success.

Financial Performance: Universal Health Realty Trust reported its financial results for the first quarter of 2026, highlighting key metrics and performance indicators.
Revenue Insights: The report includes detailed insights into revenue streams and operational performance, reflecting the trust's strategic initiatives and market conditions.
Universal Health Reality: The article discusses the concept of universal health and its implications for global health systems.
Income Trust: It highlights the role of income trusts in financing health initiatives and their impact on healthcare accessibility.
Q1 Financial Performance: The report mentions the financial performance of a specific entity in Q1, indicating a significant figure of $12.266 million.
Future Outlook: There is an emphasis on the future prospects of universal health initiatives and the importance of sustainable funding.







